FDA Approves New Treatment for Thyroid Eye Disease
-
By
-
Kathryn Wighton
-
June 29, 2026
-
3 min
By
Kathryn Wighton
June 29, 2026
Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.
October 6, 2026
Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24.
September 28, 2026
FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.
by Mouj Hijazi
October 29, 2026